Intracellular vesicle-mediated biomineralization of arsenic and barium by a sponge symbiotic bacterium
Abstract
In their soluble forms, arsenic and barium are ubiquitous toxic elements. Mechanisms for their detoxification include reducing bioavailability by assimilation into organic forms or mineralization. It was previously found that Entotheonella sp., a bacterium common to the Red Sea sponge Theonella swinhoei (Demospongiae, Tetractinellida), accumulates these elements by mineralizing them intracellularly, thus acting as a detoxifying organ to the sponge host. Here, we utilize cryo-TEM and energy-dispersive spectroscopy to investigate the accumulated minerals. Our results show that Entotheonella cells possess an internal membrane-enclosing sphere-like granules that contains barium, arsenic, sulfur, calcium, and phosphorus in high concentrations. Moreover, the bacterial cytoplasm contains many intracellular vesicles (ICVs) enriched with arsenic and sulfur. The coexistence of sulfur and arsenic may suggest the presence of cysteine-containing metal-binding proteins responsible for arsenic uptake and separation within the bacterial cell. To examine that hypothesis, we developed a protocol for vesicle isolation and performed proteomic profiling. Based on the proteins found, ICVs likely originate from the bacteria's outer membrane and contain proteins of known functions, including the transport and detoxification of toxic metals. These findings enhance our understanding of Entotheonella sp. and its host Tamiops swinhoei's unique strategies for hyper-accumulating and neutralizing toxic…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.